Hypercholesterolemia
📧 Sign up to get email alerts when something new happens for Hypercholesterolemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-01-14FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for rosuvastatin calcium submitted by Sun Pharmaceutical Industries, Inc., approving an additional f…
-
FDA approval · 2025-01-14FDA Approved: ROSUVASTATIN — Supplemental Application (ScieGen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for rosuvastatin submitted by ScieGen Pharmaceuticals, enabling the marketing of a generic rosuv…
-
FDA approval · 2025-01-14FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for Rosuvastatin Calcium from Ascend Laboratories, LLC, supporting the continued availability of a r…
-
FDA approval · 2025-01-14FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Umedica Laboratories USA Inc.)
The FDA granted supplemental approval for rosuvastatin calcium under an ANDA for Umedica Laboratories USA Inc., confirming the generic produ…
-
FDA approval · 2025-01-10FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Biocon Pharma Inc.)
FDA approved Biocon Pharma Inc.'s supplemental application for atorvastatin calcium, authorizing its continued marketing as a generic statin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: Study of QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated LDL Cholesterol [Phase 2]
This entry covers a Phase 2 clinical trial of QLC7401 for primary hypercholesterolemia or mixed hyperlipidemia with elevated LDL, which is n…
-
FDA approval · 2024-12-26FDA Approved: CHOLESTYRAMINE — Supplemental Application (EPIC PHARMA, LLC)
FDA approved a supplemental application for cholestyramine from EPIC PHARMA, LLC.
-
CLINICAL_TRIALS research · 2024-12-17Clinical Trial Update: Genetic Testing and Motivational Counseling for FH [NA]
This clinical trial update describes an ongoing study evaluating genetic testing and motivational counseling to support adherence in people …
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: Anti-eryptotic Effect of a Food Supplement with Plants Sterols in Hypercholesterolemia Treated with Statins [NA]
A University of Valencia–sponsored clinical trial evaluating a plant sterol–containing food supplement for anti-eryptotic effects in hyperch…
-
CLINICAL_TRIALS withdrawal · 2024-12-16Clinical Trial Update: Effect of Irbesartan on Endothelial Function of the Retinal Vasculature in Patients With Hypercholesterolemia [Phase 3]
The Phase 3 trial assessing irbesartan for improving retinal endothelial function in adults with hypercholesterolemia has been withdrawn.
-
FDA approval · 2024-12-09FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for a generic rosuvastatin calcium product from Quallent Pharmaceuticals Health LLC under ANDA20…
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: Evaluation of Consuming Olive Extract on Total Cholesterol Levels [NA]
A completed clinical trial evaluated whether consuming olive extract affects total cholesterol levels in people with metabolic syndrome and …
-
FDA approval · 2024-12-05FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for atorvastatin calcium from Mylan Pharmaceuticals Inc., authorizing the continued marketing of the…
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2304T and AG2304R [Phase 3]
A Phase 3 clinical trial is planned to evaluate the efficacy and safety of AG2304T and AG2304R for hypercholesterolemia; the study is not ye…
-
FDA approval · 2024-12-03FDA Approved: COLESTIPOL HYDROCHLORIDE — Original Application (Ingenus Pharmaceuticals, LLC)
FDA approved an Abbreviated New Drug Application for Colestipol hydrochloride by Ingenus Pharmaceuticals, LLC, establishing a generic versio…
-
FDA approval · 2024-11-27FDA Approved: SIMVASTATIN — Original Application (Westminster Pharmaceuticals, LLC)
FDA approved Westminster Pharmaceuticals' original application for a generic simvastatin product, adding another generic option for choleste…
-
CLINICAL_TRIALS research · 2024-11-22Clinical Trial Update: RCT for the Chinese Medicine in Treating Hypercholesterolemia [Phase 2]
A Phase 2 randomized trial evaluating a Chinese medicine formulation for hypercholesterolemia; the study is currently not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Long Term Post Marketing Specified Drug Use Result Survey for Evolocumab in Japan
A long-term post-marketing specified drug use survey for evolocumab conducted in Japan has completed.
-
FDA approval · 2024-11-21FDA Approved: CHOLESTYRAMINE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods Pharmaceuticals' original application for cholestyramine, a bile acid sequestrant, for lowering cholesterol in hyperch…
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: Impact of Alpine Dairy Products on Blood Lipid Levels [NA]
This completed clinical trial from the University of Fribourg studied whether Alpine dairy products influence blood lipid levels in people w…
-
CLINICAL_TRIALS research · 2024-11-06Clinical Trial Update: In Vitro Demonstration of Direct Platelet-Related Effects of PCSK9 Enzyme
An in vitro study demonstrates direct platelet-related effects of the PCSK9 enzyme; the trial is not yet recruiting.
-
FDA approval · 2024-11-06FDA Approved: ROSUVASTATIN — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original application for rosuvastatin by Macleods Pharmaceuticals Limited, establishing a generic rosuvastatin product. Thi…
-
CLINICAL_TRIALS research · 2024-11-04Clinical Trial Update: Natural Heart Health Supplement Trial [Phase 1]
Phase 1 clinical trial update for a natural heart health supplement from Efforia, Inc, evaluating effects on cholesterol (total and HDL); th…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Study of IBI306 in Participants With Hypercholesterolemia [Phase 3]
A Phase 3 trial evaluating IBI306 in participants with hypercholesterolemia has completed.
-
FDA approval · 2024-10-31FDA Approved: CHOLESTYRAMINE — Original Application (Macleods Pharmaceuticals Limited)
FDA approves the original ANDA for cholestyramine from Macleods Pharmaceuticals Limited, a bile acid sequestrant used to reduce elevated tot…